Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033

Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033

Including: 1) By Type: Biosimilars; Generics 2) By Therapy: Oncology Drugs; Central Nervous System Drugs; Anti-Infective Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs3) By Drug Delivery: Oral; Injectables; Dermal/Topical4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online PharmaciesCovering: Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Sun Pharmaceutical Industries Ltd.; Viatris Inc.; Abbott Laboratories


Generic Pharmaceuticals Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global generic pharmaceuticals market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for generic pharmaceuticals? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The generic pharmaceuticals market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider generic pharmaceuticals market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug delivery, by therapy and by distribution channel.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the generic pharmaceuticals market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by drug delivery, by therapy and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for generic pharmaceuticals providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Type: Biosimilars; Generics

2) By Therapy: Oncology Drugs; Central Nervous System Drugs; Anti-Infective Drugs; Respiratory Diseases Drugs; Cardiovascular Drugs; Metabolic Disorders Drugs; Musculoskeletal Disorders Drugs; Others

3) By Drug Delivery: Oral; Injectables; Dermal/Topical; Other Drug Delivery

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Teva Pharmaceutical Industries Ltd.; Sandoz Group AG; Sun Pharmaceutical Industries Ltd.; Viatris Inc.; Abbott Laboratories

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; generic pharmaceuticals indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1 Executive Summary
1.1 Generic Pharmaceuticals – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Generic Pharmaceuticals Market Definition And Segmentations
6.4 Market Segmentation By Type
6.4.1 Biosimilar
6.4.2 Generics
6.5 Market Segmentation By Drug Delivery
6.5.1 Oral
6.5.2 Injectables
6.5.3 Dermal/Topical
6.5.4 Other Drug Delivery
6.6 Market Segmentation By Therapy
6.6.1 Oncology Drugs
6.6.2 Central Nervous System (CNS) Drugs
6.6.3 Anti-Infective Drugs
6.6.4 Respiratory Diseases Drugs
6.6.5 Cardiovascular Drugs
6.6.6 Metabolic Disorders Drugs
6.6.7 Musculoskeletal Disorders Drugs
6.6.8 Others
6.7 Market Segmentation By Distribution Channel
6.7.1 Hospital Pharmacies
6.7.2 Retail Pharmacies
6.7.3 Online Pharmacies
7 Major Market Trends
7.1 Launch Of New Generic Pharmaceuticals To Broaden Patient Access To Essential Therapeutics Across Diverse Health Conditions
7.2 Introduction Of Innovative Ready-To-Use Injectable Formulations To Enhance Patient Convenience In Chemotherapy Regimens
7.3 Strategic Partnerships And Collaborations Among Major Players To Enhance Product Offerings
7.4 Strategic Launch Of Generic Oral Solutions To Enhance Market Competitiveness And Patient Access To Essential Medications
8 Generic Pharmaceuticals Market – Macro-Economic Scenario
8.1 COVID-19 Impact On The Generic Pharmaceuticals Market
8.2 Impact Of The War In Ukraine On The Generic Pharmaceuticals Market
8.3 Impact Of High Inflation On The Generic Pharmaceuticals Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)
9.2.1 Market Drivers 2018 – 2023
9.2.2 Market Restraints 2018 – 2023
9.3 Forecast Market Growth, 2023 – 2028, 2033 F Value ($ Million)
9.3.1 Market Drivers 2023 – 2028
9.3.2 Market Restraints 2023 – 2028
10 Global Generic Pharmaceuticals Market Segmentation
10.1 Global Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
10.2 Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
10.3 Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
10.4 Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
11 Generic Pharmaceuticals Market, Regional and Country Analysis
11.1 Global Generic Pharmaceuticals Market, By Region, Historic and Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
11.2 Global Generic Pharmaceuticals Market, By Country, Historic and Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.4 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.5 Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.6 China Market
12.7 Summary
12.8 Market Overview
12.8.1 Country Information
12.8.2 Market Information
12.8.3 Background Information
12.8.4 Government Initiatives
12.8.5 Regulations
12.8.6 Regulatory Bodies
12.8.7 Major Associations
12.8.8 Taxes Levied
12.8.9 Corporate Tax Structure
12.8.10 Investments
12.8.11 Major Companies
12.9 China Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.10 China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.11 China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.12 India Market
12.13 India Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.14 India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.15 India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.16 Japan Market
12.17 Japan Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.18 Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.19 Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.20 Australia Market
12.21 Australia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.22 Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.23 Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.24 Indonesia Market
12.25 Indonesia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.26 Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.27 Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.28 South Korea Market
12.29 South Korea Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.30 South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
12.31 South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Investments
13.2.11 Major Companies
13.3 Western Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.4 Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.5 Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.6 Western Europe Generic Pharmaceuticals Market: Country Analysis
13.7 UK Market
13.8 UK Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.9 UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.10 UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.11 Germany Market
13.12 Germany Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.13 Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.14 Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.15 France Market
13.16 France Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.17 France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.18 France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.19 Italy Market
13.20 Italy Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.21 Italy Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.22 Italy Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.23 Spain Market
13.24 Spain Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.25 Spain Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
13.26 Spain Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
14.4 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
14.5 Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
14.6 Eastern Europe Generic Pharmaceuticals Market: Country Analysis
14.7 Russia Market
14.8 Russia Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
14.9 Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
14.10 Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15 North America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 North America Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.4 North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.5 North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.6 North America Generic Pharmaceuticals Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
15.9.1 Country Information
15.9.2 Market Information
15.9.3 Background Information
15.9.4 Government Initiatives
15.9.5 Regulations
15.9.6 Regulatory Bodies
15.9.7 Major Associations
15.9.8 Taxes Levied
15.9.9 Corporate Tax Structure
15.9.10 Investments
15.9.11 Major Companies
15.10 USA Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.11 USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.12 USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.13 Canada Market
15.14 Canada Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.15 Canada Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
15.16 Canada Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
16 South America Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Investments
16.2.11 Major Companies
16.3 South America Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
16.4 South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
16.5 South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
16.6 South America Generic Pharmaceuticals Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
16.9 Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
16.10 Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Investments
17.2.11 Major Companies
17.3 Middle East Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
17.4 Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
17.5 Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
18 Africa Market
18.1 Summary
18.2 Market Overview
18.2.1 Region Information
18.2.2 Market Information
18.2.3 Background Information
18.2.4 Government Initiatives
18.2.5 Regulations
18.2.6 Regulatory Bodies
18.2.7 Major Associations
18.2.8 Taxes Levied
18.2.9 Corporate Tax Structure
18.2.10 Investments
18.2.11 Major Companies
18.3 Africa Generic Pharmaceuticals Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
18.4 Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
18.5 Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 – 2023, 2028 F, 2033 F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Teva Pharmaceutical Industries Ltd
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Sandoz Group AG
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 Sun Pharmaceutical Industries Ltd
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Viatris Inc
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Abbott Laboratories
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Financial Overview
20 Other Major And Innovative Companies
20.1 Dr. Reddy's Laboratories
20.1.1 Company Overview
20.1.2 Products And Services
20.2 Cipla Limited
20.2.1 Company Overview
20.2.2 Products And Services
20.3 Fresenius Kabi AG
20.3.1 Company Overview
20.3.2 Products And Services
20.4 Zydus Lifesciences Limited
20.4.1 Company Overview
20.4.2 Products And Services
20.5 Stada Arzneimittel AG
20.5.1 Company Overview
20.5.2 Products And Services
20.6 Lupin Inc
20.6.1 Company Overview
20.6.2 Products And Services
20.7 Alkem Laboratories Ltd
20.7.1 Company Overview
20.7.2 Products And Services
20.8 Amneal Pharmaceuticals, Inc
20.8.1 Company Overview
20.8.2 Products And Services
20.9 Torrent Pharmaceuticals Ltd
20.9.1 Company Overview
20.9.2 Products And Services
20.1 Sawai Group Holdings Co., Ltd
20.10.1 Company Overview
20.10.2 Products And Services
20.11 Sanofi S.A.
20.11.1 Company Overview
20.11.2 Products And Services
20.12 Hikma Pharmaceuticals PLC
20.12.1 Company Overview
20.12.2 Products And Services
20.13 Aurobindo Pharma Limited
20.13.1 Company Overview
20.13.2 Products And Services
20.14 Aspen Pharmacare Holdings Ltd
20.14.1 Company Overview
20.14.2 Products And Services
20.15 Endo International plc
20.15.1 Company Overview
20.15.2 Products And Services
21 Competitive Benchmarking
22 Competitive Dashboard
23 Key Mergers And Acquisitions
23.1 Farmak Pharmaceuticals UK Ltd. Acquired A&S Pharma Holdings
23.2 Platinum Equity Acquired A Majority Stake In Inventia Healthcare Limited
23.3 Lotus Pharmaceuticals Acquired Teva Pharma Thailand
23.4 Apotex Acquired Searchlight Pharma
23.5 Genpharmasec Limited Acquired A Majority Stake In DHPL
23.6 Lupin Limited Acquired Medisol
23.7 Sun Pharmaceutical Industries Ltd. Acquired Taro Pharmaceutical Industries Ltd.
23.8 Dr. Reddy's Laboratories Acquired Mayne Pharma’s US Generic Prescription Product Portfolio
23.9 Dr. Reddy's Laboratories Acquired Eton’s Branded And Generic Injectable Products Portfolio
24 Opportunities And Strategies
24.1 Global Generic Pharmaceuticals Market In 2028 – Countries Offering Most New Opportunities
24.2 Global Generic Pharmaceuticals Market In 2028 – Segments Offering Most New Opportunities
24.3 Global Generic Pharmaceuticals Market In 2028 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Generic Pharmaceuticals Market Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings